1.Influence of some Factors on Ribonucleolytic Activity of Black Cobra Venom
Journal of Medicinal Materials - Hanoi 2003;8(4):118-122
Among the enzymes found in snake venom, ribonuclease (RNase) has been known to have the potential effect against cancer and HIV. In a previous report, the author and his colleague have demonstrated that RNase from Vietnamese black cobra (Naja naja) venom differed from all the other identified RNase for its extremely low optimal value of pH. The results in this study showed that it also differed in nonlinear activity dependence on the enzyme concentrations and a sigmoidal curve of saturation with the substrate. This enzyme expressed the maximal activity at the ionic strength of 10 mM of the reaction buffers. Ammonium sulfate entirely suppressed the enzyme activity at the concentration over 70 mM, and sodium chloride reduced the activity by 70% at the level over 100 mM. No magnesium ion was needed for the activation of this RNase.
Snake Venoms
;
Snakes
;
Animals, Poisonous
;
Black Cobra Venom
2.Effect of Hyperkalemia and Hemolysis Caused by Hyperacute Rejection on Cardiac Function in Pig to Human Ex Vivo Xenogeneic Cardiac Perfusion Model.
Jun Seok KIM ; Hak Mo LEE ; Byoung Chol OH ; Hong Gook LIM ; Jeong Ryul LEE
Korean Circulation Journal 2011;41(3):130-136
BACKGROUND AND OBJECTIVES: Hyperacute rejection (HAR) is a major obstacle to successful xenotransplantation of vascularized organs. This study was conducted to observe the effect of hemolysis of perfused human whole blood on pig heart function, and determine the major risk factors for preservation of xenoperfused cardiac function using ex-vivo pig to human xenogeneic cardiac perfusion model. MATERIALS AND METHODS: Harvested pig hearts were perfused with normal human whole blood (group 1), two different types of pre-treated human whole blood (group 2: immunoglobulins were depleted by plasmapheresis, group 3: pre-treated with plasmapheresis, GAS914, cobra venom factor (CVF) and steroid), and normal porcine whole blood as control (group 4) for 3 hours. RESULTS: Duration of heart beat was significantly prolonged in group 2 and group 3. Histological examination showed widespread HAR features but was gradually delayed in groups 2 and 3 compared to group 1. The absolute levels of serum creatine kinase-MB and Troponin I increased gradually, and was lower in group 3. Serum hemoglobin levels were rapidly increased in groups 3 and 4, compared to group 1. Extracellular potassium level increased sharply from the beginning of blood perfusion in groups 1, 2 and 3, compared to group 4. CONCLUSION: Pretreatment of human whole blood, including immunoglobulin depletion, CVF and steroid reduced and delayed the destruction of pig myocardium by HAR. However, the increased extracellular potassium levels in groups 1, 2 and 3 reflected that these treatments could not prohibit myocardial injury by HAR.
Cobra Venoms
;
Creatine
;
Diphtheria Toxoid
;
Extracorporeal Circulation
;
Haemophilus Vaccines
;
Heart
;
Hemoglobins
;
Hemolysis
;
Humans
;
Hyperkalemia
;
Immunoglobulins
;
Myocardium
;
Perfusion
;
Plasmapheresis
;
Potassium
;
Rejection (Psychology)
;
Risk Factors
;
Transplantation, Heterologous
;
Trisaccharides
;
Troponin I
3.Anticancer Activity of Cobra Venom Polypeptide, Cytotoxin-II, against Human Breast Adenocarcinoma Cell Line (MCF-7) via the Induction of Apoptosis.
Karim EBRAHIM ; Farshad H SHIRAZI ; Hosein VATANPOUR ; Abas ZARE ; Farzad KOBARFARD ; Hadi RABIEI
Journal of Breast Cancer 2014;17(4):314-322
PURPOSE: Breast cancer is a significant health problem worldwide, accounting for a quarter of all cancer diagnoses in women. Current strategies for breast cancer treatment are not fully effective, and there is substantial interest in the identification of novel anticancer agents especially from natural products including toxins. Cytotoxins are polypeptides found in the venom of cobras and have various physiological effects. In the present study, the anticancer potential of cytotoxin-II against the human breast adenocarcinoma cell line (MCF-7) was investigated. METHODS: The cytotoxic effects of cytotoxin-II were determined by morphological analysis and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The mode and mechanism of cell death were investigated via acridine orange/ethidium bromide (AO/EtBr) double staining, flow cytometric analysis of cell death, detection of mitochondrial membrane potential, measurement of intracellular reactive oxygen species (ROS), annexin V/propidium iodide staining, and caspase-9 activity assays. RESULTS: The half maximal inhibitory concentration (IC50) of cytotoxin-II in MCF-7 cells was 4.18+/-1.23 microg/mL, while the value for cisplatin was approximately 28.02+/-1.87 microg/mL. Morphological analysis and AO/EtBr double staining showed typical manifestations of apoptotic cell death (in doses lower than 8 microg/mL). Dose- and time-dependent ROS generation, loss of mitochondrial membrane potential, caspase-9 activation, and cell cycle arrest were observed in their respective tests. CONCLUSION: In conclusion, cytotoxin-II has potent anticancer effects in the MCF-7 cell line, which are induced via the intrinsic pathways of apoptosis. Based on these findings, cytotoxin-II is a suitable choice for breast cancer treatment.
Adenocarcinoma*
;
Antineoplastic Agents
;
Apoptosis*
;
Biological Products
;
Breast Neoplasms
;
Breast*
;
Caspase 9
;
Cell Cycle Checkpoints
;
Cell Death
;
Cell Line*
;
Cisplatin
;
Cobra Venoms*
;
Cytotoxins
;
Diagnosis
;
Elapidae
;
Female
;
Humans
;
MCF-7 Cells
;
Membrane Potential, Mitochondrial
;
Peptides
;
Reactive Oxygen Species
;
Snakes
;
Venoms
4.A Pig to Canine Auxiliary Hepatic Xenotransplantation Model: Prevention of Hyperacute Rejection via Blocking the Kupffer Cells and Regulating the Complement Family.
Jae Jeong PARK ; Ku Yong CHUNG ; Jeong Eun LEE ; Cha Kyong YOM ; Jae Gil LEE ; Hyung Joon AHN ; Sei Kwan OH ; Sun Hee SUNG ; Byung Chul KANG ; Ki Hwan HAN
Journal of the Korean Surgical Society 2008;75(5):287-295
PURPOSE: We designed a pig to canine liver xenotransplantation model to study the diverse immunologic and hemodynamic consequences that follow xenotransplantation and hyperacute rejection. METHODS: The animals were divided into two groups: the cobra venom factor and Gadolinium chloride treatment group (CVF+Gd group) (3 cases) and the control group (3 cases). The donor pig's whole liver was harvested, and then the harvested pig's whole liver was transplanted into a dog after the dog underwent left hepatectomy. After reperfusion of the graft, blood samples were taken 20, 40 and 60 minutes after reperfusion, and the liver, lung and kidney tissues were taken 1 hour after reperfusion. RESULTS: In the control group, the grafts showed a patchy hypoperfused liver surface and it felt rubbery solid compared to the CVF+Gd group. The serum total protein, albumin, fibrinogen and platelets decreased abruptly and there were no significant differences between the two groups. The serum PT, PTT and FDP were increased in both groups and the CVF+Gd group showed a more obtuse slope than the control group. We could not find any intravascular pathologic changes on the microscopic findings of the graft. Only scant intravascular fibrin deposition was found. Hepatocellular vacuolization and sinusoidal dilatation were also found. There were patches of necrosis without any zonal distribution, intrasinusoidal neutrophil sequestration and interstitial hemorrhage. These findings were milder in the CVF+Gd group. CONCLUSION: The pig to canine partial auxiliary liver xenotransplantation model is feasible and it is a good model before starting to perform pig to primate liver xenotransplantation. In the CVF+Gd group, pathologic findings like patch hepatocyte necrosis etc. were less severe. As there were no corresponding vascular pathologic findings, these findings are not the direct effect of CVF and gadolinium treatment, and so other factors like Ischemia- reperfusion injury should be considered.
Animals
;
Blood Platelets
;
Cobra Venoms
;
Complement System Proteins
;
Dilatation
;
Dogs
;
Fibrin
;
Fibrinogen
;
Fluconazole
;
Formycins
;
Gadolinium
;
Hemodynamics
;
Hemorrhage
;
Hepatectomy
;
Hepatocytes
;
Humans
;
Kidney
;
Kupffer Cells
;
Liver
;
Lung
;
Necrosis
;
Neutrophils
;
Primates
;
Rejection (Psychology)
;
Reperfusion
;
Reperfusion Injury
;
Ribonucleotides
;
Tissue Donors
;
Transplantation, Heterologous
;
Transplants
5.Guangxi cobra venom-derived NGF promotes the osteogenic and therapeutic effects of porous BCP ceramic.
Pan JIN ; Fuqiang YIN ; Li HUANG ; Li ZHENG ; Jinmin ZHAO ; Xingdong ZHANG
Experimental & Molecular Medicine 2017;49(4):e312-
Neuro-osteological interactions have an important role in the regulation of bone metabolism and regeneration. Neuropeptides combined with porous biphasic calcium phosphates (BCP) using protein adsorption may contribute to the acceleration of bone formation. In the present study, we investigated the effect of BCP combined with nerve growth factor (NGF) on the growth of osteoblasts in vitro and the combinational therapeutic effect on the repair of calvarial defects in vivo. NGF was separated and purified from Chinese cobra venom using a simplified three-step chromatography method. BCP combined with NGF exerted a potent effect on osteoblast differentiation, as evidenced by enhanced cell proliferation, increased ALP activity and the up-regulated expression of osteogenesis-related genes and proteins. Further, combinational therapy with BCP and NGF improved calvarial regeneration, which was superior to treatment with therapy alone, as observed using imageological and morphological examination and histological and immunohistochemical staining. The results confirmed the effect of neuro-osteological interactions through combinatorial treatment with NGF and BCP to promote osteogenesis and bone formation, which may provide an effective and economical strategy for clinical application.
Acceleration
;
Adsorption
;
Asian Continental Ancestry Group
;
Calcium Phosphates
;
Cell Proliferation
;
Ceramics*
;
Chromatography
;
Cobra Venoms
;
Elapidae*
;
Humans
;
In Vitro Techniques
;
Metabolism
;
Methods
;
Nerve Growth Factor*
;
Neuropeptides
;
Osteoblasts
;
Osteogenesis
;
Regeneration
;
Therapeutic Uses*